![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H30N4O3 |
Molar mass | 410.518 g·mol−1 |
3D model (JSmol) | |
| |
|
Protonitazene is a benzimidazole derivative with potent opioid effects which has been sold over the internet as a designer drug since 2019, and has been identified in various European countries, as well as Canada, the US and Australia. [1] It has been linked to numerous cases of drug overdose, and is a Schedule I drug in the US. [2] [3] [4] [5] [6]
It was developed by a Swiss pharmaceutical company in the 1950s as an alternative to morphine, but was never adopted due to severe side effects. [7]
Protonitazen er et syntetisk opioid som ble utviklet av et sveitsisk legemiddelselskap på 50-tallet. Det var ment som et alternativ til morfin, men på grunn av alvorlige bivirkninger ble stoffet aldri tatt i bruk.[Protonitazen is a synthetic opioid that was developed by a Swiss pharmaceutical company in the 50s. It was intended as an alternative to morphine, but due to severe side effects, the drug was never used.]